Arrowstreet Capital’s Parexel International Corp PRXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-119,000
Closed -$10.3M 1347
2017
Q2
$10.3M Buy
119,000
+74,800
+169% +$5.58M 0.03% 353
2017
Q1
$2.79M Buy
+44,200
New +$2.92M 0.01% 719
2015
Q4
Sell
-19,748
Closed -$1.22M 1678
2015
Q3
$1.22M Sell
19,748
-61,989
-76% -$4.17M 0.01% 872
2015
Q2
$5.26M Buy
81,737
+33,300
+69% +$2.24M 0.03% 415
2015
Q1
$3.34M Buy
48,437
+2,108
+5% +$134K 0.02% 502
2014
Q4
$2.57M Buy
+46,329
New +$2.67M 0.01% 656
2014
Q2
Sell
-37,935
Closed -$2.05M 1305
2014
Q1
$2.05M Sell
37,935
-8,223
-18% -$421K 0.01% 655
2013
Q4
$2.08M Buy
+46,158
New +$2.11M 0.01% 650

Other funds holding PRXL

Arrowstreet Capital's PRXL Position: Q3 2017 in Review

Arrowstreet Capital sold out of Parexel International Corp (PRXL) in Q3 2017, closing a stake of 119,000 shares — an estimated $10.3M sold.

Arrowstreet Capital first reported a position in PRXL in Q4 2013 and held it in 8 quarters. The position peaked at $10.3M in Q2 2017. 246 funds tracked by Wall St. Rank hold PRXL as of Q3 2017.

  • Arrowstreet Capital reported no remaining Parexel International Corp position as of Q3 2017 after selling out during the quarter.
  • Arrowstreet Capital sold 119,000 Parexel International Corp shares in Q3 2017, an estimated $10.3M.
  • Arrowstreet Capital first reported a position in Parexel International Corp in Q4 2013 and held it in 8 quarters.
  • Arrowstreet Capital's Parexel International Corp position peaked at $10.3M in Q2 2017.
  • 246 funds tracked by Wall St. Rank held Parexel International Corp as of Q3 2017.

Based on Arrowstreet Capital's 13F filing for Q3 2017, filed 14 Nov 2017.